nutrients-logo

Journal Browser

Journal Browser

The Effect of Anti-inflammatory Food on Resisting Cardiocerebrovascular Diseases and Cognition

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Metabolism".

Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 7719

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurology, National Cerebral and Cardiovascular, Osaka 564-8565, Japan
Interests: stroke; dementia; neurology

Special Issue Information

Dear Colleagues,

More than 100 candidates of disease-modifying drugs for dementia have failed to be established despite the clarification of the underlying mechanisms in basic research using animal models.

Late-life dementia is characterized by multiple exacerbating factors, consisting of not only neurodegeneration but also multiple overlapping features, including vascular risk factors (e.g., hypertension, diabetes mellitus, and obesity), a history of cerebrovascular diseases, and chronic inflammation. Furthermore, neurodegeneration and cerebrovascular lesions are two leading attributable risks to the development of dementia. The neurovascular unit, which consists of the blood–brain barrier (BBB), plays an important role in the integrity of brain health. BBB dysfunction not only induces red blood cell extravasation but may also aggravate the homeostasis of the internal environment in the brain with increased inflammation and oxidative stress, all of which can lead to cognitive impairment. Improved nutrition, foods, or supplements, such as omega 3 and fish oil, can protect the blood–brain barrier integrity by reducing neuroinflammation. Thus, targeting vascular risk factors and aspects of the cerebrovascular system, such as the neurovascular unit, with improved nutrition or diets may be indispensable for the treatment or prevention of late-life dementia.

Dr. Yorito Hattori
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vascular dementia
  • vascular cognitive impairment
  • Alzheimer’s dementia
  • anti-inflammatory foods
  • anti-inflammatory supplements

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Jump to: Other

24 pages, 1369 KiB  
Review
Capsaicin: A Potential Treatment to Improve Cerebrovascular Function and Cognition in Obesity and Ageing
by Tammy Thornton, Dean Mills and Edward Bliss
Nutrients 2023, 15(6), 1537; https://doi.org/10.3390/nu15061537 - 22 Mar 2023
Cited by 5 | Viewed by 4689
Abstract
Impaired cognition is the primary symptom of dementia, which can lead to functional disability and reduced quality of life among an increasingly ageing population. Ageing is associated with increased oxidative stress, chronic low-grade systemic inflammation, and endothelial dysfunction, which reduces cerebrovascular function leading [...] Read more.
Impaired cognition is the primary symptom of dementia, which can lead to functional disability and reduced quality of life among an increasingly ageing population. Ageing is associated with increased oxidative stress, chronic low-grade systemic inflammation, and endothelial dysfunction, which reduces cerebrovascular function leading to cognitive decline. Chronic low-grade systemic inflammatory conditions, such as obesity, exacerbate this decline beyond normal ageing and predispose individuals to neurodegenerative diseases, such as dementia. Capsaicin, the major pungent molecule of chilli, has recently demonstrated improvements in cognition in animal models via activation of the transient receptor potential vanilloid channel 1 (TRPV1). Capsaicin-induced TRPV1 activation reduces adiposity, chronic low-grade systemic inflammation, and oxidative stress, as well as improves endothelial function, all of which are associated with cerebrovascular function and cognition. This review examines the current literature on capsaicin and Capsimax, a capsaicin supplement associated with reduced gastrointestinal irritation compared to capsaicin. Acute and chronic capsaicin treatment can improve cognition in animals. However, studies adequately assessing the effects of capsaicin on cerebrovascular function, and cognition in humans do not exist. Capsimax may be a potentially safe therapeutic intervention for future clinical trials testing the effects of capsaicin on cerebrovascular function and cognition. Full article
Show Figures

Graphical abstract

Other

Jump to: Review

11 pages, 666 KiB  
Commentary
How Alpha Linolenic Acid May Sustain Blood–Brain Barrier Integrity and Boost Brain Resilience against Alzheimer’s Disease
by Alicia Leikin-Frenkel, Michal Schnaider Beeri and Itzik Cooper
Nutrients 2022, 14(23), 5091; https://doi.org/10.3390/nu14235091 - 30 Nov 2022
Cited by 6 | Viewed by 2590
Abstract
Cognitive decline, the primary clinical phenotype of Alzheimer’s disease (AD), is currently attributed mainly to amyloid and tau protein deposits. However, a growing body of evidence is converging on brain lipids, and blood–brain barrier (BBB) dysfunction, as crucial players involved in AD development. [...] Read more.
Cognitive decline, the primary clinical phenotype of Alzheimer’s disease (AD), is currently attributed mainly to amyloid and tau protein deposits. However, a growing body of evidence is converging on brain lipids, and blood–brain barrier (BBB) dysfunction, as crucial players involved in AD development. The critical role of lipids metabolism in the brain and its vascular barrier, and its constant modifications particularly throughout AD development, warrants investigation of brain lipid metabolism as a high value therapeutic target. Yet, there is limited knowledge on the biochemical and structural roles of lipids in BBB functionality in AD. Within this framework, we hypothesize that the ApoE4 genotype, strongly linked to AD risk and progression, may be related to altered fatty acids composition in the BBB. Interestingly, alpha linolenic acid (ALA), the precursor of the majoritarian brain component docosahexaenoic acid (DHA), emerges as a potential novel brain savior, acting via BBB functional improvements, and this may be primarily relevant to ApoE4 carriers. Full article
Show Figures

Graphical abstract

Back to TopTop